newsfilter
← Latest News
GlobeNewswire·

Geron Corporation to Participate in the Stifel 2026 Healthcare Conference

  • Geron Corporation (NASDAQ: GERN) announced management participation in a fireside chat & one-on-one meetings at the Stifel 2026 Healthcare Conference.
  • The event is scheduled for Tuesday, November 10, 2026, at 2:00 p.m. ET in New York, NY.
  • A live & archived audio webcast will be accessible via the Investor section of Geron's website at www.geron.com.
  • Geron is a commercial-stage hematology-focused biopharmaceutical company with offices in Parsippany, New Jersey, & Foster City, California.
  • The company's medicine, RYTELO (imetelstat), is approved in the United States & European Union for patients with lower-risk myelodysplastic syndromes (LR-MDS).
  • Dawn Schottlandt serves as Senior Vice President, Investor Relations & Corporate Affairs, with contact email dschottlandt@geron.com.